Список литературы (часть 2)

16.01.2012г.

Дифлунизал

Brogden R. N., Heel R. C, Pakes G. E. et al. A review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis. — Drugs, 1980, 19, 84.

Van Winzum C, Verhaest L. In Huskisson (Ed.) Diflunisal, Clinics in Rheumatic Diseases Vol. 5 Anti-Rheumatic Drugs, p. 707. Saunders, London, 1979.

Фенилбутазон

Aarbakke I., Bakke O. M.. Milde E. J., Davies D. S. Disposition and oxidative metabolism of phenylbutazone in man. — Europ. J. clin. Pharmacology, 1977, 11, 359.

Boobis S. W., Chignell С F. Effect of protein concentration on the binding of drugs to human serum albumin: Sulfadiazine, salicylate and phenylbutazone. — Biochem. Pharmacol, 1979, 28, 751.

Committee on the Review of Medicines. Recommendations on phenylbutazone, oxphenbutazone, feprazone, allopurinol, colchicine, probenecid and sulphin-pyrazone. — Brit. med. J, 1978, 1,1466.

Domenjoz R. The pharmacology of phenylbutazone analogues. — Ann. N. Y. Acad. Sci, 1960, 86, 263.

Domenjoz R. Synthetic anti-inflammatory drugs. Concepts on their mode of action. — Advances in Pharmacol, 1966, 4, 143.

F´aigle I. W., Dieterle W. The biotransformation of phenylbutazone (Butazoli-din). — J. International Med. Research, 1977, 2 (Suppl.), 2.

Fowler P. D. Marrow toxicity of the pyrazoles. — Ann. rheumat. Dis, 1967, 26, 344. 

Fowler P. D., Faragher E. B. Drug and non-drug factors influencing adverse reactions to pyrazoles. — J. international med. Research, 1977, 5 (Suppl. 2), 108. 

Hansen J. M., Christensen L. K. Drug interactions with oral sulphonylurea hypoglycaemic drugs. — Drugs, 1977, 13, 24. Hart F. D. Current therapeutics: Phenvlbutazone. — Practitioner, 1953, 171, 84.

Inman W. H. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. — Brit. med. J., 1977, 1, 1500.

Koch-Weser J., Sellers E. M. Drug interactions with coumarin anticoagulants. —  New Engl. J. med., 1971, 285, 487, 547.

Kutt H. Interactions of antiepileptic drugs. — Epilepsia, 1975, 16, 393.

Smyth С J., Percy J. S. Comparison of indomethacin and phenylbutazone in acute gout. — Ann. rheumat. Dis., 1973, 32, 351.

Stevenson A. C, Bedford J., Hill A. G. S., Hill H. F. H. Chromosomal studies in patients taking phenylbutazone. — Ann. rheumat. Dis., 1971, 30, 487.

von Rechenberg H. K. Phenylbutazone, 2nd ed. Edward Arnold, London, 1962.

Walker S., Price Evans D. A., Benn P. A. et al. Phenylbutazone and chromosomal damage. — Ann. rheumat. Dis., 1975, 34, 409.

Азапропазон

Grennan D. M., Watkins C, Kennedy A. C. Preliminary clinical evaluation of azapropazone in rheumatic arthritis. — Curr. med. Res. Opinion., 1974, 2, 67.

Hart F. D. Azapropazone: A review of the literature. — Europ. J. RheumatoL Inflammation, 1978, 1, 142.

McElnay J. C, D´Arcy P. F. The effect of azapropazone on the binding of warfarin to human serum proteins. — J. Pharm. Pharmacol., 1978, 30, 73.

Resent advances in clinical rheumatology: A review and clinical assessment of azapropazone. — Curr. med. Res. Opinion., 1976, 4, 3.

Sondervorst M. Azapropazone. in Huskisson (Ed.) Clinics in Rheumatic Diseases Vol. 5. Anti-Rheumatic Drugs, p. 465. Saunders, London, 1979.

Фепразон

Chierichetti S., Bianchi G., Cerri B. Comparison of feprazone and phenylbutazone interaction with warfarin in man. — Curr. Therapeutic Res., 1975„ 18, 568.

Feprazone. — Scand. J. rheumatol., 1975, 4, Suppl. 8.

Symposium on Feprasone. IXth European Congress of Rheumatology, Wiesbaden. Excerpta Medica, Amsterdam, 1979.

Reardon J. A., Stackman A., Darlington L. G., Scott J. T. Double blind trial of feprazone and phenylbutazone in acute gout. — Curr. Med. Res. Opinion., 1980, 6, 445.

Индометацин

Baber N., Halliday L. D. C, van den Heuvel W. J. A. et al. Indomethacin in* rheumatoid arthritis: Clinical effects, pharmacokinetics and platelet studies in responders and non-responders. — Ann. rheumat. Dis., 1979, 38, 128.

Brooks P. M., Bell M. A., Sturrock R. D. et al. The clinical significance of in-domethacin-probenecid interaction. — Brit. J. clin Pharmacol., 1974, 1, 287.

Brooks P. M., Walker J. J., Bell M. A. et al. Indomethacin-aspirin interaction; a clinical appraisal. — Brit. med. J., 1975, 3, 69.

Garnham J. C, Raymond K., Shotton E., Turner P. The effect of buffered aspirin on plasma indomethacin. — Europ. J. clin. Pharmacol., 1975, 8, 107.

Hart F. D., Boardman P. L. Indomethacin: a new non-steroidal anti-inflammatory agent. — Brit. med. J., 1963, 2, 965.

Hart F. D., Boardman P. L. Indomethacin. — Practitioner, 1964, 192, 828.

Hart F. D., Boardman P. L. Indomethacin and phenylbutazone. A comparison. —  Brit. med. J., 1965, 2, 1281.

Lindquist В., Moller J., Johansson H., Hansen T. Effect of concurrent administration of aspirin and indomethacin on serum concentrations. — Clin,. Pharmacol. Ther., 1974, 15, 247.

Murthy M. H. V., Rhymer A. R., Wright V. Indomethacin or prednisolone at night in rheumatoid arthritis? — Rheum. Rehabilitation., 1978, 17, 8.

Smith D. E., Brater D. C, Lin E. T. et al. Attenuation of furosemide´s diuretic effect by indomethacin. — J. of Pharmacokinetics and Biopharmaceutics, 1979, 7, 265.

Vessel E. S., Passananti G. T.s Johnson Alice O. Failure of indomethacin and warfarin to interact in normal human voluteers. — J. clin. Pharmacol., 1975, 15, 486.

Watkins J., Abbott E. C, Hensby C. N. et al. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. — Brit. med. J., 1980, 281, 702.

«Лечение ревматических заболеваний»,
под ред. Ф.Д.Харта





Читайте далее: